Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride, and glisoxepide
- 1 December 1971
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 7 (6) , 455-460
- https://doi.org/10.1007/bf01212062
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepideDiabetologia, 1971
- [Current pathophysiological and clinical aspects of the mode of action of blood glucose lowering sulfonamides].1969
- [Further studies on the dynamic aspects of insulin release in vitro with evidence for a two-compartmental storage system].1969
- Glybenclamid (HB 419): ein neues orales Antidiabetikum der Sulfonylharnstoff-ReiheDeutsche Medizinische Wochenschrift (1946), 1969
- Etude expérimentale d'un nouveau sulfamide hypoglycémiant particulièrement actif, le HB 419 ou glibenclamideDiabetologia, 1969
- The Acute Insulin Synergistic Activity of Growth Hormone - II) Reversal of Chronic Growth Hormone Effect by Actinomycin DHormone and Metabolic Research, 1969
- Dynamics of Insulin Secretion by the Perfused Rat PancreasEndocrinology, 1968
- Über die radioimmunologische Bestimmung von Insulin im BlutKlinische Wochenschrift, 1965
- Microdetermination of Long-chain Fatty Acids in Plasma and TissuesJournal of Biological Chemistry, 1960
- Zum Wirkungsmechanismus blutzuckersenkender Sulfonylharnstoffe D 860 und BZ 551Deutsche Medizinische Wochenschrift (1946), 1959